demyelinating polyneuropathy

de·my·e·li·nat·ing pol·y·neu·rop·a·thy

a type of polyneuropathy in which almost solely the peripheral nerve myelin is affected; can be familial (for example, Charcot-Marie-Tooth disease, type 1) or acquired (for example, Guillain-Barré syndrome); on motor nerve conduction studies, manifested as conduction slowing or block.
References in periodicals archive ?
The GBS subtypes identified were acute inflammatory demyelinating polyneuropathy (21.
Electrodiagnostic studies performed 10 days post-onset identified demyelinating polyneuropathy consistent with GBS (online Technical Appendix, https://wwwnc.
immunomodulation in adults, children and adolescents (0-18 years) at: - primary immune thrombocytopenia in patients at high risk of bleeding or pre-treatment for platelet count, - guillain-barr syndrome, - kawasaki~s disease, - chronic inflammatory demyelinating polyneuropathy.
Acute inflammatory demyelinating polyradiculoneuropathy (AIDP), hypoKPP, and (in view of the recurrence) Chronic inflammatory demyelinating polyneuropathy (CIDP) were all considered in the differential diagnosis.
Enlargement of nerve roots, which is a distinct feature of hypertrophic neuropathy, has been frequently reported in neurofibromatosis and chronic inflammatory demyelinating polyneuropathy (CIDP).
M2 EQUITYBITES-September 15, 2017-CSL Behring wins US FDA approval for Privigen for the treatment of adults with chronic inflammatory demyelinating polyneuropathy
Here, we present a 46-year-old woman who was diagnosed with anti-MDA5-mediated demyelinating polyneuropathy clinically mimicking dermatomyositis.
Guillain-Barre syndrome (GBS) is an acute autoimmune inflammatory demyelinating polyneuropathy.
Second, because of the clinical similarity between AFM and other neurologic conditions such as idiopathic transverse myelitis and acute inflammatory demyelinating polyneuropathy subtype of Guillain-Barre syndrome, cases might be misdiagnosed and not reported to state and local health departments.
M2 PHARMA-July 20, 2017-CSL Behring submits supplemental BLA for Hizentra with the US FDA for treating Chronic Inflammatory Demyelinating Polyneuropathy
GBS subtypes are recognised on the basis of electrodiagnostic and pathologic distinctions and it included Acute Inflammatory Demyelinating Polyneuropathy (AIDP), the most common variant followed by two axonal variants-Acute Motor Sensory Axonal Neuropathy (AMSAN) and Acute Motor Axonal Neuropathy (AMAN).
1] Commonly known as acute inflammatory demyelinating polyneuropathy (AIDP), GBS's spectrum has expanded in recent years to include variants with unusual attributes.